Vicore Pharma Holding AB
STO:VICO

Watchlist Manager

Vicore Pharma Holding AB

STO:VICO

Watchlist

Dividends

Discount Rate

Price: 7.91 SEK 1.67% Market Closed

Market Cap: 1.9B SEK

Have any thoughts about
Vicore Pharma Holding AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 7.91 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VICO Alert

Vicore Pharma Holding AB

7.91

+0.13 (+1.67%)

52 Week Range	6.9665 23.3
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Vicore Pharma Holding AB

What unique competitive advantages
does Vicore Pharma Holding AB hold over its rivals?

What risks and challenges
does Vicore Pharma Holding AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Vicore Pharma Holding AB.

What unique competitive advantages
does Vicore Pharma Holding AB hold over its rivals?

What risks and challenges
does Vicore Pharma Holding AB face in the near future?

Has there been any significant insider trading activity
in Vicore Pharma Holding AB recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vicore Pharma Holding AB.

Provide P/S
for Vicore Pharma Holding AB.

Provide P/E
for Vicore Pharma Holding AB.

Provide P/OCF
for Vicore Pharma Holding AB.

Provide P/FCFE
for Vicore Pharma Holding AB.

Provide P/B
for Vicore Pharma Holding AB.

Provide EV/S
for Vicore Pharma Holding AB.

Provide EV/GP
for Vicore Pharma Holding AB.

Provide EV/EBITDA
for Vicore Pharma Holding AB.

Provide EV/EBIT
for Vicore Pharma Holding AB.

Provide EV/OCF
for Vicore Pharma Holding AB.

Provide EV/FCFF
for Vicore Pharma Holding AB.

Provide EV/IC
for Vicore Pharma Holding AB.

Show me price targets
for Vicore Pharma Holding AB made by professional analysts.

What are the Revenue projections
for Vicore Pharma Holding AB?

How accurate were the past Revenue estimates
for Vicore Pharma Holding AB?

What are the Net Income projections
for Vicore Pharma Holding AB?

How accurate were the past Net Income estimates
for Vicore Pharma Holding AB?

What are the EPS projections
for Vicore Pharma Holding AB?

How accurate were the past EPS estimates
for Vicore Pharma Holding AB?

What are the EBIT projections
for Vicore Pharma Holding AB?

How accurate were the past EBIT estimates
for Vicore Pharma Holding AB?

Compare the revenue forecasts
for Vicore Pharma Holding AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vicore Pharma Holding AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vicore Pharma Holding AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vicore Pharma Holding AB compared to its peers.

Compare the P/E ratios
of Vicore Pharma Holding AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Vicore Pharma Holding AB with its peers.

Analyze the financial leverage
of Vicore Pharma Holding AB compared to its main competitors.

Show all profitability ratios
for Vicore Pharma Holding AB.

Provide ROE
for Vicore Pharma Holding AB.

Provide ROA
for Vicore Pharma Holding AB.

Provide ROIC
for Vicore Pharma Holding AB.

Provide ROCE
for Vicore Pharma Holding AB.

Provide Gross Margin
for Vicore Pharma Holding AB.

Provide Operating Margin
for Vicore Pharma Holding AB.

Provide Net Margin
for Vicore Pharma Holding AB.

Provide FCF Margin
for Vicore Pharma Holding AB.

Show all solvency ratios
for Vicore Pharma Holding AB.

Provide D/E Ratio
for Vicore Pharma Holding AB.

Provide D/A Ratio
for Vicore Pharma Holding AB.

Provide Interest Coverage Ratio
for Vicore Pharma Holding AB.

Provide Altman Z-Score Ratio
for Vicore Pharma Holding AB.

Provide Quick Ratio
for Vicore Pharma Holding AB.

Provide Current Ratio
for Vicore Pharma Holding AB.

Provide Cash Ratio
for Vicore Pharma Holding AB.

What is the historical Revenue growth
over the last 5 years for Vicore Pharma Holding AB?

What is the historical Net Income growth
over the last 5 years for Vicore Pharma Holding AB?

What is the current Free Cash Flow
of Vicore Pharma Holding AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vicore Pharma Holding AB.

VICO

Balance Sheet

Accrued Liabilities

Vicore Pharma Holding AB
Accrued Liabilities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Vicore Pharma Holding AB
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

	Accrued Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Vicore Pharma Holding AB STO:VICO	Accrued Liabilities kr17.1m	CAGR 3-Years -3%	CAGR 5-Years 27%	CAGR 10-Years N/A
Biogaia AB STO:BIOG B	Accrued Liabilities kr86.4m	CAGR 3-Years 21%	CAGR 5-Years 9%	CAGR 10-Years N/A
Bonesupport Holding AB STO:BONEX	Accrued Liabilities N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
Vitrolife AB STO:VITR	Accrued Liabilities kr190m	CAGR 3-Years 15%	CAGR 5-Years 11%	CAGR 10-Years N/A
Swedish Orphan Biovitrum AB (publ) STO:SOBI	Accrued Liabilities N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
BioArctic AB STO:BIOA B	Accrued Liabilities kr43m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap

1.9B SEK

Industry

Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

Open VICO Analysis

VICO Intrinsic Value

2.94 SEK

Overvaluation 63%

Intrinsic Value

Price

What is Intrinsic Value?

What is Vicore Pharma Holding AB's Accrued Liabilities?

Accrued Liabilities
17.1m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Accrued Liabilities amounts to 17.1m SEK.

What is Vicore Pharma Holding AB's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
27%

Over the last year, the Accrued Liabilities growth was 0%. The average annual Accrued Liabilities growth rates for Vicore Pharma Holding AB have been -3% over the past three years , 27% over the past five years .

Vicore Pharma Holding AB
STO:VICO

Vicore Pharma Holding AB
Accrued Liabilities

Vicore Pharma Holding AB
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Vicore Pharma Holding AB
Glance View

See Also

What is Vicore Pharma Holding AB's Accrued Liabilities?

Accrued Liabilities
17.1m SEK

What is Vicore Pharma Holding AB's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
27%

Company

Help

Tools

Stocks

Vicore Pharma Holding AB STO:VICO

Vicore Pharma Holding AB Accrued Liabilities

Vicore Pharma Holding AB Accrued Liabilities Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Vicore Pharma Holding AB Glance View

See Also

What is Vicore Pharma Holding AB's Accrued Liabilities? Accrued Liabilities 17.1m SEK

What is Vicore Pharma Holding AB's Accrued Liabilities growth rate? Accrued Liabilities CAGR 5Y 27%

Company

Help

Tools

Stocks

Vicore Pharma Holding AB
STO:VICO

Vicore Pharma Holding AB
Accrued Liabilities

Vicore Pharma Holding AB
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Vicore Pharma Holding AB
Glance View

What is Vicore Pharma Holding AB's Accrued Liabilities?

Accrued Liabilities
17.1m SEK

What is Vicore Pharma Holding AB's Accrued Liabilities growth rate?

Accrued Liabilities CAGR 5Y
27%